Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of desflurane and remifentanil is a balanced anesthesia approach used in various surgical procedures. This combination leverages the complementary properties of both agents to provide effective anesthesia with favorable recovery profiles. ## Pharmacological Properties Desflurane is a volatile inhalational anesthetic with low blood solubility, allowing for rapid induction and emergence from anesthesia[8]. Remifentanil is an ultra short-acting synthetic opioid with rapid onset and offset of action, making it ideal for continuous infusion during surgical procedures[5]. When used together, remifentanil reduces the required concentration of desflurane in a dose-dependent manner. Studies have shown that remifentanil at doses of 0.1, 0.15, or 0.25 μg/kg/min can reduce desflurane requirements by 74%, 83%, and 90% respectively[1]. This synergistic effect allows for lower concentrations of desflurane while maintaining adequate anesthesia. ## Clinical Applications The desflurane-remifentanil combination has been successfully used in various surgical settings: - General surgery and ambulatory procedures[6] - Otorhinolaryngeal surgery[7] - Tympanoplasty and endoscopic sinus surgery[4] - Cesarean section deliveries[3] - Laparoscopic procedures[6] ## Advantages This combination offers several clinical benefits: 1. **Improved hemodynamic stability**: The combination helps maintain stable blood pressure and heart rate during surgery[3]. 2. **Faster recovery**: Studies show shorter emergence times and faster achievement of discharge criteria compared to other anesthetic regimens[6][7]. 3. **Dose-dependent effects**: Remifentanil reduces desflurane requirements without increasing recovery time, allowing for tailored anesthesia[1][2]. 4. **Effective hypotensive anesthesia**: The combination provides good surgical conditions in terms of operative field quality, particularly beneficial in procedures where bleeding control is important[4]. ## Recommended Dosing For optimal results, studies recommend using remifentanil at 2 ng/ml or less combined with desflurane to decrease the concentration of desflurane without significant side effects during the maintenance phase of anesthesia[2]. Typical infusion rates range from 0.05 to 0.2 μg/kg/min for remifentanil alongside variable concentrations of desflurane (2-8%)[6]. ## Safety Considerations While generally well-tolerated, the combination may cause dose-dependent decreases in heart rate, particularly at higher remifentanil doses (0.15 or 0.25 μg/kg/min)[1]. However, studies have shown no significant differences in postoperative nausea and vomiting, pain, or the need for rescue medications compared to other anesthetic regimens[6]. In cesarean section procedures, the combination has been shown to be safe for both mother and newborn, with no significant impact on Apgar scores or umbilical artery blood pH values[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on desflurane + remifentanil.